Streetbeat News

Products Services

AAPL

BBY

Apple Inc.'s new M3 MacBook Pro is already discounted by $100 on Best Buy Co Inc., merely two days after its launch. The discount is applicable on all configurations and is offered to My Best Buy Plus or Total members, both existing and new.

Portfolio Pulse from Rounak Jain

November 02, 2023 | 12:02 pm

AUVI

Applied UV has secured a new patent approval from the USPTO for an interchangeable drain disinfecting device. The device is currently undergoing validation at Mt Sinai Hospital.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:02 pm

RGEN

Repligen Corporation has announced the commercial launch of TangenX SC, the industry's first holder-free, self-contained tangential flow filtration device. This innovative product is expected to revolutionize the bioprocessing industry.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:56 am

KURA

MRTX

Kura Oncology and Mirati Therapeutics have entered into a clinical collaboration and supply agreement to evaluate KO-2806 and Adagrasib for non-small cell lung cancer.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:55 am

LNG

Cheniere Energy has announced that its subsidiary, Cheniere Marketing, has signed a long-term liquefied natural gas (LNG) sale and purchase agreement with Foran Energy Group Co. Ltd.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:50 am

BDX

Becton, Dickinson and Company (BDX) has launched a new needle-free blood draw technology that is compatible with integrated catheters. This innovation aligns with the company's vision of a 'one-stick hospital stay'.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:50 am

INTS

Intensity Therapeutics presented safety, tolerability, and efficacy data from its ongoing Phase 1/2 trial of INT230-6 in relapsed, refractory, and metastatic sarcomas at the Connective Tissue Oncology Society 2023 Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:48 am

NFLX

Netflix Inc. (NASDAQ:NFLX) has announced an upgrade to its ad-supported plan, allowing users to download movies and shows. The downloaded content will be ad-free, making Netflix the only ad-supported streaming service to offer this feature. The company's ad-supported package has 15 million active users globally each month. Netflix also plans to introduce new ad formats, including live sponsors for sports events and ads with QR codes. This move comes after a recent price hike in Netflix’s subscription costs in the US, UK, and France.

Portfolio Pulse from Rounak Jain

November 02, 2023 | 11:47 am

TRVI

Trevi Therapeutics has initiated its Phase 2A RIVER trial of Haduvio in refractory chronic cough patients. The topline data from this trial is expected to be released in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:46 am

ACXP

Acurx Pharmaceuticals announced top-line results from Phase 2 trials of Ibezapolstat, showing a 96% clinical cure rate in patients with C. difficile infection. The drug was well tolerated with no serious adverse events reported. Further analyses are forthcoming, and preparations are underway for an End-of-Phase 2 FDA meeting and advancement to Phase 3. Despite the positive results, Acurx's shares experienced a selloff.

Portfolio Pulse from Charles Gross

November 02, 2023 | 11:45 am